Bone & Cartilage Support
Natural health product licensed in Canada
- Licence holder
- Sancta Health Canada Inc.
- NPN or DIN-HM
- 80090630
- Status
- Active licence
- Licence date
- 15 February 2019
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Citrate de calcium | 50 milligramme | 200,000 µg |
| Vitamine D Source : Cholécalciférol | 200 Unités internationales | Not calculated |
| Vitamine K2 Source : Vitamin K2 | 30 microgrammes | Not calculated |
| Collagène hydrolysé Source : Collagène hydrolysé | 300 milligramme | Not calculated |
| Morus alba Source : Écorce de racine Extract : Matériel brut sec Extraction ratio : 22.5:1 Dry plant equivalent : 1,500.75 milligramme | 66.7 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 2 days |
Uses authorised in Canada
AmLexin provides antioxidants. Vitamin D3 helps in the absorption and use of calcium and phosphorus. Adequate calcium and vitamin D throughout life as part of a healthy diet, along with physical activity may help prevent bone loss/osteoporosis. Adequate calcium and vitamin D throughout life as part of a healthy diet, along with physical activity may reduce the risk of developing osteoporosis. Helps in the development and maintenance of bones and teeth. Helps to reduce joint pain associated with osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are pregnant or breastfeeding, do not use this product.
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. If you have liver or kidney disease or if you have been instructed to follow a low protein diet, consult a health care practitioner prior to use.
- Effets indésirables connus
May cause mild gastrointestinal disturbances.
Source
Official Health Canada record, licence 80090630
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.